Some other targets are currently being evaluated for B cell lymphoma, such as CD20 (NCT03576807, NCT03664635), CD22 [123,124], receptor tyrosine kinase-like orphan receptor 1 (ROR1) (NCT02706392), and Ig kappa chain [125], to address these challenges. Here, ROR1 is linked to B-cell non-Hodgkin lymphoma.